Resources
About Us
Meticulous Research®—a leading global market research company, published a research report titled “Antimicrobial Susceptibility Testing Market Size, Share, Forecast, & Trends Analysis by Product (Susceptibility Disks, Plates, MIC Strip) Test Type (Antibacterial, Antifungal) Method (Diffusion, Automated) Application End User—Global Forecast to 2031.”
According to this latest publication from Meticulous Research®, the antimicrobial susceptibility testing market is expected to reach $7.21 billion by 2031, at a CAGR of 6.7% during the forecast period. The growth of this market is primarily driven by the growing risk of infectious diseases, rising incidences of infections due to antimicrobial-resistant pathogens, and growing concerns related to antimicrobial resistance globally. Moreover, supportive initiatives and funding for research in the area of AMR also support market growth. Furthermore, active R&D to develop rapid antimicrobial susceptibility testing and growth prospects in emerging markets are offering market opportunities.
Key Players
The key players profiled in the antimicrobial susceptibility testing market report are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), HiMedia Laboratories Pvt. Ltd. (India), MERLIN Diagnostika GmbH (Germany), Accelerate Diagnostics, Inc. (U.S.), Alifax S.r.l. (Italy), Creative Diagnostics (U.S.), Synbiosis (U.K.), and Zhuhai DL Biotech Co., Ltd (China).
The global antimicrobial susceptibility testing market is segmented by Product (Manual AST Products {Susceptibility Disks, Susceptibility Plates, and MIC Strips}, Consumables, and Automated AST Products), Method (Disk Diffusion, Automated AST, Dilution, and Other Methods), Test Types (Antibacterial Tests, Anti-parasitic Tests, Antifungal Tests, and Other Test Types), Application (Clinical Diagnostics, Drug Discovery, and Development, Other Applications), End User (Diagnostic Laboratories & Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Institutes), Geography. The study also evaluates industry competitors and analyzes their market share at a global and regional level.
Among all the products covered in the report, in 2024, the manual antimicrobial susceptibility testing products segment is expected to account for the largest share of the antimicrobial susceptibility testing market. The large market share of this segment is driven by the low cost of manual AST products and simple handling procedures. The availability of a diverse range of consumables for manual testing and easy interpretation of tests are supporting market growth.
Among all the methods covered in the report, in 2024, the disk diffusion segment is expected to account for the largest share of the antimicrobial susceptibility testing market. The low cost associated with performing AST testing through the disk diffusion method and developments in the disk diffusion method with the use of automated technology is primarily supporting the segment’s large share. The disk diffusion method (also called the Kirby-Bauer method) is among the most flexible susceptibility testing methods used in clinical settings. This method is simple and practical and offers flexibility for the compounds being tested cost-effectively. It offers qualitative and interpretative results. Disk tests can be performed with Mueller-Hinton agar, which is available from multiple manufacturers and can be used with little or no requirement for additional instrumentation (e.g., calipers, a ruler, and an incubator). This makes it the least costly of all susceptibility methods.
Among all the test types studied in the report, in 2024, the antibacterial tests segment is expected to account for the largest share of the antimicrobial susceptibility testing market. The large market share of this segment is attributed to the higher use of antibacterial tests in clinical diagnosis, the growing incidence of bacterial infections, the emergence of antibiotic-resistant bacteria, cost-effectiveness, simple and fast interpretation, and ease of use and availability.
Among all the applications studied in the report, in 2024, the clinical diagnostics segment is expected to account for the largest share of the antimicrobial susceptibility testing market. The large market share of this segment is attributed to the rising burden of antimicrobial resistance and growing awareness about the use of antimicrobial susceptibility testing methods.
Among all the end users studied in the report, in 2024, the diagnostic laboratories and hospitals segment is expected to account for the largest share of the antimicrobial susceptibility testing market. The large market share of this segment is attributed to the availability of well-equipped facilities and trained/skilled technicians, the rise in hospital-acquired infections, and initiatives taken by key players to offer AST products through diagnostic laboratories & hospitals.
Geographic Review
This research report analyzes major geographies and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America, and the Middle East & Africa. North America is expected to account for the largest share of the antimicrobial susceptibility testing market in 2024, followed by Europe and Asia-Pacific. Factors driving the North American market include the adoption of technologically advanced susceptibility testing methods and continuous research for new drugs using ASTs, along with awareness about treatment options. Favorable government initiatives also support the growth of the North America market. For instance, in October 2020, the National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020–2025, was designed for coordinated, strategic actions to improve the health and well-being of all Americans by changing the course of antibiotic resistance.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5062
Key questions answered in the report-
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
India VNA & PACS Market to Reach $341.6 Million by 2031
Read MoreChina Microarray Market to Be Worth $910.4 Million by 2031
Read MoreChina Neurogenomics Market to Reach $562.1 Million by 2031
Read MoreELISA Market to be Worth $32.69 Billion by 2031
Read MoreDNA Sequencing Market to be Worth $21.30 Billion by 2031
Read MoreOral Care Market to be Worth $58.99 Billion by 2031
Read MoreSpirometer Market to be Worth $1.80 Billion by 2031
Read MorePet Care Market to be Worth $287.96 Billion by 2031
Read MoreRegenerative Medicine Market to be Worth $37.27 Billion by 2031
Read MoreHemostats Market to be Worth $5.32 Billion by 2031
Read MoreBioreactors Market to be Worth $39.96 Billion by 2031
Read MoreProtein Assays Market to be Worth $4.36 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreAsia-Pacific NGS Automation Market to be Worth $371 Million by 2031
Read MoreLatin America NGS Market to be Worth $765.2 Million by 2031
Read MoreBiochemical Reagents Market to be Worth $39.61 Billion by 2031
Read MoreMicroarray Kits Market to be Worth $2.51 Billion by 2031
Read MoreAntibody Production Market to Reach $58.35 Billion by 2031
Read MoreMiddle East IVD Market to be Worth $2.15 Billion by 2031
Read MoreSpatial Genomics Market to be Worth $3.23 Billion by 2031
Read MoreAsia-Pacific IVD Market to be Worth $36.02 Billion by 2031
Read MoreEurope NGS Market to be Worth $6.40 Billion by 2030
Read MoreLab Automation Market to be Worth $11.31 Billion by 2031
Read MoreBioinformatics Market to Reach $31.71 Billion by 2031
Read MoreEurope IVD Market to be Worth $39.77 Billion by 2030
Read MoreSequencing Kits Market to be Worth $25.29 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreSample Preparation Market to be Worth $12.77 Billion by 2031
Read MoreSurgical Robots Market Worth $25.47 Billion by 2030
Read MoreMedical Coatings Market Worth $3.32 Billion by 2030
Read MoreLiquid Handling Systems Market Worth $6.99 Billion by 2029
Read MoreElectrosurgery Market to be Worth $8.99 Billion by 2031
Read MoreRadiation Dose Management Market Worth $749.1 Million by 2029
Read MoreMolecular Diagnostics Market Worth $46.69 Billion by 2030
Read MoreNewborn Screening Market to be Worth $2.69 Billion by 2031
Read MorePharmacogenomics Market to be Worth $19.5 Billion by 2031
Read MoreDental Practice Management Software Market Worth $ 3.11 Billion by 2029
Read MoreNepal IVD Market Worth $62.7 Million by 2029
Read MorePharmaceutical Contract Packaging Market Worth $42.03 Billion by 2029
Read MoreIndonesia IVD Market Worth $1.11 Billion by 2029
Read MoreMedical Waste Management Market Worth $17.02 billion by 2030
Read MoreEmpty Capsules Market Worth $4.47 Billion by 2029
Read MoreClear Aligners Market to be worth $18.8 Billion by 2030
Read MoreHLA Typing Market Worth $1.9 Billion by 2029
Read MoreReal-world Data Market Worth $1.66 billion by 2029
Read MoreTrack and Trace Solutions Market Worth $27.27 billion by 2029
Read MoreSurface Disinfectant Market Worth $9.52 Billion by 2029
Read MoreElectronic Lab Notebook Market Worth $787.7 million by 2029
Read MoreRapid Diagnostics Market to be Worth $22.65 Billion By 2031
Read MorePlasma Therapy Market Worth $882.5 Million by 2028
Read MorePeripheral Vascular Devices Market Worth $12.02 Billion by 2028
Read MoreBiomaterials Market to Reach 128.7 Billion USD by 2023
Read MoreVaccine Storage Equipment Market Worth $1.83 billion by 2027
Read MorePlasma Fractionation Market Worth $46.9 Billion by 2029
Read MoreHome Healthcare Market to be Worth $514.5 Billion by 2030
Read MoreCardiac Pacemaker Devices Market Worth $4.34 Billion by 2028
Read MoreEuropean Laboratory Informatics Market Worth $1,084.3 Million By 2024
Read MoreCompetent Cells Market Worth 2,318.6 Million USD By 2023
Read MoreCancer Immunotherapy Market to be Worth $267.2 Billion by 2030
Read MoreMultimodal Imaging Market Worth $1.6 Billion By 2024
Read MorePulse Lavage Market to be Worth $661.1 Million by 2030
Read MoreMedical Cooling Systems Market Worth $2.8 Billion By 2024
Read MoreTissue Diagnostics Market Worth $8.52 Billion by 2029
Read MoreEndoscopy Equipment Market Worth $59.8 Billion by 2029
Read MoreAfrican Forensic DNA Testing Market Worth $136.3 Million by 2025
Read MoreClinical Trial Supplies Market to be Worth $5.59 Billion by 2031
Read MoreInfection Control Market Worth $58.2 Billion by 2027
Read MoreSleep Apnea Devices Market Worth $12.9 billion by 2027
Read MoreMedical 3D Printing Market To Reach $983.2 Million By 2020
Read MoreGenomics Market to be Worth $70.52 Billion by 2031
Read MoreAnalytical Standards Market Worth $2.66 Billion By 2027
Read MoreTelehealth Market Worth $539.73 Billion by 2029
Read MoreCell Culture Market Worth $48.63 Billion by 2029
Read MoreAntimicrobial Coatings Market to be Worth $12.41 Billion by 2031
Read MoreFlow Cytometry Market Worth $6.4 Billion by 2027
Read MoreMedical Aesthetics Market Worth $29.43 billion by 2029
Read MoreOligonucleotide Synthesis Market Worth $3.9 Billion by 2025
Read MoreIn Vitro Diagnostics Market to be Worth $116.28 Billion by 2031
Read MoreDental Implants Market Worth $6.52 Billion by 2029
Read MoreActive Implantable Devices Market Worth 24.02 Billion USD By 2022
Read MoreVentilators Market to be Worth $13.23 Billion by 2031
Read MoreDialysis Market to be Worth $36.6 Billion by 2031
Read MorePlasmapheresis Market to be Worth $2.55 Billion by 2030
Read MoreDiabetes Care Devices Market Worth $31.9 Billion by 2028
Read MoreClinical Genomics Market Worth 879.0 Million USD By 2023
Read MoreIVD Quality Control Market to be Worth $2.28 Billion by 2031
Read MoreLaboratory Informatics Market Worth $6.1 Billion by 2030
Read MoreChromatography Data Systems Market to be Worth $1.7 billion by 2030
Read MoreBone Growth Stimulators Market Worth $1.94 Billion by 2030
Read MoreDigital Diabetes Market worth $12.03 billion by 2025
Read MoreTrocars Market Worth $968.5 Million by 2024
Read MoreHealthcare Virtual Assistant Market Worth $1.76 Billion By 2025
Read MoreEurope Hospital Beds Market to be Worth $2.09 Billion by 2030
Read MoreImmunoassay Market Worth $46.49 Billion by 2028
Read MoreHospital Beds Market Worth $ 6.66 Billion by 2030
Read MoreUrinalysis Market Worth $2.19 billion by 2027
Read MoreMedical Image Management Market Worth $7.22 billion by 2030
Read MoreBreast Imaging Market Worth $7.08 Billion by 2027
Read MoreVNA & PACS Market to be Worth $6.50 Billion by 2031
Read More